Suppr超能文献

外用皮质类固醇和外用钙调神经磷酸酶抑制剂在薄嫩及敏感皮肤区域特应性皮炎治疗中的应用。

Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.

作者信息

Draelos Zoe D

机构信息

Wake Forest University School of Medicine, Winston-Salem, NC, USA.

出版信息

Curr Med Res Opin. 2008 Apr;24(4):985-94. doi: 10.1185/030079908x280419. Epub 2008 Feb 18.

Abstract

BACKGROUND

Atopic dermatitis (AD) is a common, chronic skin disorder characterized by itch and dry skin, which can develop into pruritic red plaques that ooze when scratched. AD flares often occur in anatomic areas where the skin is naturally thin (the face, neck, and intertriginous zones). Such regions, especially the face, are also areas of sensitive skin and need special consideration when being treated.

OBJECTIVE

This article will briefly review the concepts of thin and sensitive skin and discuss the treatment of AD in such areas.

METHODS

The MEDLINE database was searched for English-language articles published that contained the text terms atopic dermatitis, sensitive skin, treatment, topical corticosteroids, or topical calcineurin inhibitors. Articles that pertained to the safety and efficacy of various treatments were selected for further review.

RESULTS

Topical corticosteroids (TCSs) are effective for the treatment of AD in thin and sensitive skin areas, but their use is limited due to adverse events, such as skin thinning, and the potential for impairing the skin barrier. Topical calcineurin inhibitors (TCIs) also provide effective AD treatment without impairing the skin barrier or inducing skin thinning. Although TCIs may be associated with a higher incidence of application-site reactions such as pruritus and skin burning, these symptoms are typically transient and mild to moderate in nature.

LIMITATIONS

This analysis focused primarily on relatively recent key trials evaluating the treatment of AD in sensitive skin; due to the limited number of controlled trials evaluating TCS agents, consensus statements and comprehensive review articles were used for most of the information pertaining to this therapeutic option.

CONCLUSIONS

Although both TCSs and TCIs have a place in a long-term, comprehensive treatment strategy for AD, TCIs may have a particular use in thin and sensitive skin areas.

摘要

背景

特应性皮炎(AD)是一种常见的慢性皮肤病,其特征为瘙痒和皮肤干燥,可发展为瘙痒性红色斑块,搔抓后会渗出液体。AD发作常发生在皮肤天然较薄的解剖部位(面部、颈部和间擦疹部位)。这些区域,尤其是面部,也是敏感皮肤区域,在治疗时需要特别考虑。

目的

本文将简要回顾薄皮肤和敏感皮肤的概念,并讨论此类区域AD的治疗。

方法

在MEDLINE数据库中检索发表的英文文章,这些文章包含特应性皮炎、敏感皮肤、治疗、外用糖皮质激素或外用钙调神经磷酸酶抑制剂等文本术语。选择与各种治疗的安全性和有效性相关的文章进行进一步综述。

结果

外用糖皮质激素(TCSs)对薄皮肤和敏感皮肤区域的AD治疗有效,但由于诸如皮肤变薄等不良事件以及损害皮肤屏障的可能性,其使用受到限制。外用钙调神经磷酸酶抑制剂(TCIs)也能有效治疗AD,且不会损害皮肤屏障或导致皮肤变薄。尽管TCIs可能与更高的应用部位反应发生率相关,如瘙痒和皮肤烧灼感,但这些症状通常是短暂的,且性质为轻度至中度。

局限性

本分析主要集中在评估敏感皮肤中AD治疗的相对近期的关键试验;由于评估TCS药物的对照试验数量有限,大部分与该治疗选择相关的信息使用了共识声明和综合综述文章。

结论

尽管TCSs和TCIs在AD的长期综合治疗策略中都有一席之地,但TCIs在薄皮肤和敏感皮肤区域可能有特殊用途。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验